Skip to main content

COVID-19 Rapid Guideline: Managing Symptoms (Including at the End of Life) in the Community [NG191]

CPG
Date: Tuesday, March 23, 2021

Overview

Recommendations for managing COVID‑19 symptoms for patients in the community, including at the end of life. This guideline was updated and replaces NICE COVID-19 rapid guideline NG163.

Get The CPG

Members Only Content

Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.

Yes, sign me up for an APTA membership!

Already a member? Log in

Share This
Resource Details

Date: March 23, 2021
Contact:  practice@apta.org
Content Type:  CPG

Symptoms & Conditions

Lung Conditions, Respiratory Conditions, COVID-19

Patient Age

Child (6-12), Middle Aged (45-64), Adolescent (13-18), Young Adult (19-24), Adult (25-44), Aged (65+), 80 and over (80+)

Author(s)

National Institute for Health and Care Excellence

You Might Also Like...

CPG

Respiratory Management of Patients With Neuromuscular Weakness

Mar 13, 2023

This joint guideline by the American College of Chest Physicians and Canadian Thoracic Society covers the prevention of acute exacerbations experienced

Clinical Summary

Long COVID

Sep 23, 2022

Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. As of July 19, 2022, over 559 million cases of COVID-19 and 6.3

CPG

COVID-19 Rapid Guideline: Managing the Long-term Effects of COVID-19 [NG188]

Nov 11, 2021

This "living" guideline covers identifying, assessing, and managing the long-term effects of COVID-19, frequently described as "long COVID." It makes recommendations